We offer interactive workshops on project valuation, license contract structuring and portfolio management. Our expertise is within advanced financial modeling, forecasting, simulation and R&D strategy.
Mastering valuation is a central issue for several stakeholders in the Life Sciences industry. For example, when a biotechnology firm considers investing in an internal R&D project or choose among several R&D projects, raise external funds, engage in license contracts with potential partners, plan to go public via an initial public offering or are subject to mergers or acquisitions, one need to assess a value of the R&D projects and/or firm. Knowing the intrinsic value of an R&D asset can be critical for getting the best deal terms from either side of the negotiating table. Investors also need to master valuation in order to make rational investment decisions.
License contract valuation
Licensing play an integral part of the business model of licensors (biotech) and licensees (pharma) in the drug development industry. The current deal trend of increasing complexity of licensee contracts, including sublicensing, co-development, call-back options, profit sharing, tiered royalties, or sales milestones make valuation a challenge. Traditional rules of thumb, such as the value share principle commonly employed by big pharma, are not sufficient anymore as guidelines in negotiations of deal terms. We ensure that you understand how even the most complicated license contracts translate into value in order not to leave value on the negotiation table in partnering discussions.
Workshop
This interactive hands-on workshop will teach you how to structure valuation models in Excel, understand drivers of value and how to structure and value license deals. You will know your leeway and have rational arguments to ask for better deal terms. We will teach you the most recent topics and developments in the field of deal structures to help you assess and improve deal terms in partnering discussions.
This workshop is ideal for executives, senior management, strategy and business development professionals, investment bankers and investors.
We also tailor workshops to serve our clients needs.